Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

Treating KRAS-mutated NSCLC

Non-G12C mutations: Future perspectives

Date

13 Sep 2024

Session

Treating KRAS-mutated NSCLC

Topics

Clinical Research;  Cancer Biology;  Pathology/Molecular Biology;  Translational Research;  Targeted Therapy;  Molecular Oncology;  Genetic and Genomic Testing

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Colin Lindsay

Authors

C. Lindsay

Author affiliations

  • Medical Oncology Department, The Christie NHS Foundation Trust, M20 4BX - Manchester/GB

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

G12C targeted therapies

Presenter: Natasha Leighl

Session: Treating KRAS-mutated NSCLC

Resources:

Slides

Webcast

Combinations with IO

Presenter: Jarushka Naidoo

Session: Treating KRAS-mutated NSCLC

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.